1. Home
  2. VLY vs DAWN Comparison

VLY vs DAWN Comparison

Compare VLY & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLY
  • DAWN
  • Stock Information
  • Founded
  • VLY 1927
  • DAWN 2018
  • Country
  • VLY United States
  • DAWN United States
  • Employees
  • VLY N/A
  • DAWN N/A
  • Industry
  • VLY Major Banks
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VLY Finance
  • DAWN Health Care
  • Exchange
  • VLY Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • VLY 5.1B
  • DAWN 1.3B
  • IPO Year
  • VLY N/A
  • DAWN 2021
  • Fundamental
  • Price
  • VLY $9.16
  • DAWN $12.79
  • Analyst Decision
  • VLY Hold
  • DAWN Strong Buy
  • Analyst Count
  • VLY 10
  • DAWN 7
  • Target Price
  • VLY $9.60
  • DAWN $36.17
  • AVG Volume (30 Days)
  • VLY 5.5M
  • DAWN 937.9K
  • Earning Date
  • VLY 01-23-2025
  • DAWN 10-30-2024
  • Dividend Yield
  • VLY 4.79%
  • DAWN N/A
  • EPS Growth
  • VLY N/A
  • DAWN N/A
  • EPS
  • VLY 0.62
  • DAWN N/A
  • Revenue
  • VLY $1,577,035,000.00
  • DAWN $101,953,000.00
  • Revenue This Year
  • VLY N/A
  • DAWN N/A
  • Revenue Next Year
  • VLY $7.09
  • DAWN $36.10
  • P/E Ratio
  • VLY $14.70
  • DAWN N/A
  • Revenue Growth
  • VLY N/A
  • DAWN N/A
  • 52 Week Low
  • VLY $6.47
  • DAWN $11.94
  • 52 Week High
  • VLY $11.18
  • DAWN $18.07
  • Technical
  • Relative Strength Index (RSI)
  • VLY 31.05
  • DAWN 39.97
  • Support Level
  • VLY $8.90
  • DAWN $12.26
  • Resistance Level
  • VLY $10.27
  • DAWN $12.81
  • Average True Range (ATR)
  • VLY 0.33
  • DAWN 0.52
  • MACD
  • VLY -0.19
  • DAWN -0.05
  • Stochastic Oscillator
  • VLY 14.21
  • DAWN 28.94

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company whose principal wholly-owned subsidiary is Valley National Bank. It provides a full range of commercial, retail, and trust and investment services largely through its offices and ATM network throughout northern and central New Jersey, New York City Long Island, Florida, and Alabama. The segments of the group are commercial lending, consumer lending, investment management, and corporate and other adjustments, of which key interest income is derived from the commercial lending segment. In recent years, the company has focused on acquiring companies that operate outside of traditional banking and has emphasized wealth and capital management.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

Share on Social Networks: